A comprehensive view of United Therapeutics Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

District Court denies United Therapeutics' motion for injunction to block launch of Liquidia's YUTREPIA in PH-ILD indication; ruling clears path for FDA to issue final decision on amended NDA

INTERNATIONAL PATENT: UNITED THERAPEUTICS CORPORATION FILES APPLICATION FOR "METHODS FOR TREATING PULMONARY HYPERTENSION"

'Treatment Of Pulmonary Arterial Hypertension With Prostacyclin-Treated Endothelial Progenitor Cells' in Patent Application Approval Process (USPTO 20240131078)

United Therapeutics Corp. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (May 1, 2024)

'Stable Treprostinil Prodrugs' in Patent Application Approval Process (USPTO 20240130989)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count